The company now has enough money for commercialization in the US Nyxoah, a medtech company that combats sleep apnea with an implantable neurostimulator, signed an agreement with the European Investment Bank (EIB) for a credit facility of 37.5 million EUR at the beginning of July.…
EFI11 July 2024